Cefaloram

This classification denotes a cephalosporin antibiotic with the molecular formula C18H18N2O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) K3086GQJ9Z, chemically known as (6r,7r)-3-(acetoxymethyl)-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure but more generally known as cefaloram, which bears US NIH Compound Identifier 68940. European Medicines Agency schedules Cefaloram in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06168MIG. The term CEFALORAM is an International Non-Proprietary Name. CEFALORAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule cefaloram under HS 29419000 and SITC 54139. As of Q4 2014, CEFALORAM remains US FDA's Preferred Term for this commodity. Cefaloram bears US NLM identifiers UMLS ID C0637533 and NCI Concept Code C76156. SMILES: S1C2N(C(=O)C2NC(=O)CC2CCCCC2)C(=C(C1)COC(=O)C)C(=O)O.